Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting

Frontiers in Neural Circuits

Volumn 3, Issue NOV, 2009, Pages

  Zhang, Yuchun ^a   Llinas, Rodolfo R ^b   Lisman, John E ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Burst; Delta oscillation; Nmda receptor; Nucleus reticularis; Resting potential; TCD; Thalamus

Indexed keywords

EID: 77953604398     PISSN: 16625110     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.04.020.2009     Document Type: Article

References (77)

1. Akbarian, S., Kim, J. J., Potkin, S. G., Hagman, J. O., Tafazzoli, A., Bunney, W. E., Jr., and Jones, E. G. (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266.
2. Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., and Bertram, L. (2008). Systematic meta-analyses and fi eld synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40, 827-834.
3. Anaya-Martinez, V., Martinez-Marcos, A., Martinez-Fong, D., Aceves, J., and Erlij, D. (2006). Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior. Neuroscience 143, 477-486.
4. Anchisi, D., Scelfo, B., and Tempia, F. (2001). Postsynaptic currents in deep cerebellar nuclei. J. Neurophysiol. 85, 323-331.
5. Andreasen, N. C. (1997). The role of the thalamus in schizophrenia. Can. J. Psychiatry 42, 27-33.
6. Bal, T., and McCormick, D. A. (1993). Mechanisms of oscillatory activity in guinea-pig nucleus reticularis thalami in vitro: a mammalian pacemaker. J. Physiol. (Lond.) 468, 669-691.
7. Behrendt, R. P. (2006). Dysregulation of thalamic sensory "transmission" in schizophrenia: neurochemical vulnerability to hallucinations. J. Psychopharmacol. (Oxford) 20, 356-372.
8. Benes, F. M., and Berretta, S. (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27.
9. Boutros, N. N., Arfken, C., Galderisi, S., Warrick, J., Pratt, G., and Iacono, W. (2008). The status of spectral EEG abnormality as a diagnostic test for schizophrenia. Schizophr. Res. 99, 225-237.
10. Buzsaki, G. (1991). The thalamic clock: emergent network properties. Neuroscience 41, 351-364.
11. Contreras, D., Curro Dossi, R., and Steriade, M. (1993). Electrophysiological properties of cat reticular thalamic neurones in vivo. J. Physiol. (Lond.) 470, 273-294.
12. Cox, C. L., Huguenard, J. R., and Prince, D. A. (1995). Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K conductance. J. Neurophysiol. 74, 990-1000.
13. Coyle, J. T. (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 3, 241-253.
14. Coyle, J. T. (2006). Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26, 365-384.
15. Cueni, L., Canepari, M., Lujan, R., Emmenegger, Y., Watanabe, M., Bond, C. T., Franken, P., Adelman, J. P., and Luthi, A. (2008). T-type Ca2 channels, SK2 channels and SERCAs gate sleeprelated oscillations in thalamic dendrites. Nat. Neurosci. 11, 683-692.
16. Destexhe, A., Hughes, S. W., Rudolph, M., and Crunelli, V. (2007). Are corticothalamic 'up' states fragments of wakefulness? Trends Neurosci. 30, 334-342.
17. Espinosa, F., Torres-Vega, M. A., Marks, G. A., and Joho, R. H. (2008). Ablation of Kv3.1 and Kv3.3 potassium channels disrupts thalamocortical oscillations in vitro and in vivo. J. Neurosci. 28, 5570-5581.
18. Featherstone, D. E., and Shippy, S. A. (2008). Regulation of synaptic transmission by ambient extracellular glutamate. Neuroscientist. 14, 171-181.
19. Fehr, T., Kissler, J., Moratti, S., Wienbruch, C., Rockstroh, B., and Elbert, T. (2001). Source distribution of neuromagnetic slow waves and MEG-delta activity in schizophrenic patients. Biol. Psychiatry 50, 108-116.
20. Garcia-Cabezas, M. A., Martinez-Sanchez, P., Sanchez-Gonzalez, M. A., Garzon, M., and Cavada, C. (2009). Dopamine innervation in the thalamus: monkey versus rat. Cereb. Cortex 19, 424-434.
21. Grunze, H. C., Rainnie, D. G., Hasselmo, M. E., Barkai, E., Hearn, E. F., McCarley, R. W., and Greene, R. W. (1996). NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16, 2034-2043.
22. Herman, M. A., and Jahr, C. E. (2007). Extracellular glutamate concentration in hippocampal slice. J. Neurosci. 27, 9736-9741.
23. Huguenard, J. R., and Prince, D. A. (1992). A novel T-type current underlies prolonged Ca2+-dependent burst fi ring in GABAergic neurons of rat thalamic reticular nucleus. J. Neurosci. 12, 3804-3817.
24. Ibrahim, H. M., Hogg, A. J. Jr., Healy, D. J., Haroutunian, V., Davis, K. L., and Meador-Woodruff, J. H. (2000). Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry 157, 1811-1823.
25. Jahnsen, H., and Llinas, R. (1984a). Electrophysiological properties of guinea-pig thalamic neurones: an in vitro study. J. Physiol. (Lond.) 349, 205-226.
26. Jahnsen, H., and Llinas, R. (1984b). Ionic basis for the electro-responsiveness and oscillatory properties of guinea-pig thalamic neurones in vitro. J. Physiol. (Lond.) 349, 227-247.
27. Javitt, D. C., and Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
28. Jeanmonod, D., Schulman, J., Ramirez, R., Cancro, R., Lanz, M., Morel, A., Magnin, M., Siegemund, M., Kronberg, E., Ribary, U., and Llinas, R. (2003). Neuropsychiatric thalamocortical dysrhythmia: surgical implications. Thalamus Relat. Syst. 103-113.
29. Jones, E. G. (2002). Thalamic circuitry and thalamocortical synchrony. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 357, 1659-1673.
30. Kanyshkova, T., Pawlowski, M., Meuth, P., Dube, C., Bender, R. A., Brewster, A. L., Baumann, A., Baram, T. Z., Pape, H. C., and Budde, T. (2009). Postnatal expression pattern of HCN channel isoforms in thalamic neurons: relationship to maturation of thalamocortical oscillations. J. Neurosci. 29, 8847-8857.
31. Karavanova, I., Vasudevan, K., Cheng, J., and Buonanno, A. (2007). Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta- galactosidase knock-in mice. Mol. Cell. Neurosci. 34, 468-480.
32. Khan, Z. U., Gutierrez, A., Martin, R., Penafiel, A., Rivera, A., and De La Calle, A. (1998). Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J. Comp. Neurol. 402, 353-371.
33. Knott, V., Labelle, A., Jones, B., and Mahoney, C. (2001). Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophr. Res. 50, 41-53.
34. Krause, M., Hoffmann, W. E., and Hajos, M. (2003). Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats. Biol. Psychiatry 53, 244-253.
35. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers, M. B. Jr., and Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199-214.
36. Kuner, T., and Schoepfer, R. (1996). Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. J. Neurosci. 16, 3549-3558.
37. Langsjo, J. W., Kaisti, K. K., Aalto, S., Hinkka, S., Aantaa, R., Oikonen, V., Sipila, H., Kurki, T., Silvanto, M., and Scheinin, H. (2003). Effects of subanesthetic doses of ketamine on regional cerebral blood fl ow, oxygen consumption, and blood volume in humans. Anesthesiology 99, 614-623.
38. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., Baldwin, R. M., Seibyl, J. P., Krystal, J. H., Charney, D. S., and Innis, R. B. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A. 93, 9235-9240.
39. Lavin, A., and Grace, A. A. (1998). Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro. J. Neurosci. 18, 10566-10578.
40. Le Meur, K., Galante, M., Angulo, M. C., and Audinat, E. (2007). Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus. J. Physiol. (Lond.) 580, 373-383.
41. Lewis, D. A., Cruz, D. A., Melchitzky, D. S., and Pierri, J. N. (2001). Lamina-specifi c defi cits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 158, 1411-1422.
42. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., and Grace, A. A. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242.
43. Llinas, R., and Geijo-Barrientos, E. (1988). In vitro studies of mammalian thalamic and reticularis thalami neurons. In Cellular Thalamic Mechanisms, M. Bentivoglio and R. Spreafi co, eds (Amsterdam, Elsevier), pp. 23-33.
44. Llinas, R., and Jahnsen, H. (1982). Electrophysiology of mammalian thalamic neurones in vitro. Nature 297, 406-408.
45. Llinas, R., Urbano, F. J., Leznik, E., Ramirez, R. R., and van Marle, H. J. (2005). Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci. 28, 325-333.
46. Llinas, R. R., Ribary, U., Jeanmonod, D., Kronberg, E., and Mitra, P. P. (1999). Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc. Natl. Acad. Sci. U.S.A. 96, 15222-15227.
47. McCormick, D. A. (1989). Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci. 12, 215-221.
48. McCormick, D. A., and Bal, T. (1997). Sleep and arousal: thalamocortical mechanisms. Annu. Rev. Neurosci. 20, 185-215.
49. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., and Seeburg, P. H. (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
50. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., and Seeburg, P. H. (1992). Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
51. Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., and Goldman-Rakic, P. S. (1996). Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381, 245-248.
52. Murthy, V. N., Sejnowski, T. J., and Stevens, C. F. (2000). Dynamics of dendritic calcium transients evoked by quantal release at excitatory hippocampal synapses. Proc. Natl. Acad. Sci. U.S.A. 97, 901-906.
53. Nakki, R., Nickolenko, J., Chang, J., Sagar, S. M., and Sharp, F. R. (1996). Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp. Neurol. 137, 234-241.
54. Neborsky, R., Janowsky, D., Munson, E., and Depry, D. (1981). Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations. Arch. Gen. Psychiatry 38, 195-199.
55. O'Donnell, P., and Grace, A. A. (1993). Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens. J. Neurosci. 13, 3456-3471.
56. Olney, J. W., Newcomer, J. W., and Farber, N. B. (1999). NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 33, 523-533.
57. Otmakhova, N. A., and Lisman, J. E. (1996). D1/D5 dopamine receptor activation increases the magnitude of early longterm potentiation at CA1 hippocampal synapses. J. Neurosci. 16, 7478-7486.
58. Pilowsky, L. S., Bressan, R. A., Stone, J. M., Erlandsson, K., Mulligan, R. S., Krystal, J. H., and Ell, P. J. (2006). First in vivo evidence of an NMDA receptor defi - cit in medication-free schizophrenic patients. Mol. Psychiatry 11, 118-119.
59. Popken, G. J., Bunney, W. E. Jr., Potkin, S. G., and Jones, E. G. (2000). Subnucleus-specifi c loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U.S.A. 97, 9276-9280.
60. Rockstroh, B. S., Wienbruch, C., Ray, W. J., and Elbert, T. (2007). Abnormal oscillatory brain dynamics in schizophrenia: a sign of deviant communication in neural network? BMC Psychiatry 7, 44.
61. Sah, P., Hestrin, S., and Nicoll, R. A. (1989). Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science 246, 815-818.
62. Seeman, P. (1987). Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152.
63. Sharp, F. R., Butman, M., Wang, S., Koistinaho, J., Graham, S. H., Sagar, S. M., Noble, L., Berger, P., and Longo, F. M. (1992). Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J. Neurosci. Res. 33, 605-616.
64. Sharp, F. R., Tomitaka, M., Bernaudin, M., and Tomitaka, S. (2001). Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci. 24, 330-334.
65. Snyder, S. H. (1976). The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry 133, 197-202.
66. Steriade, M., Amzica, F., and Contreras, D. (1996). Synchronization of fast (30- 40 Hz) spontaneous cortical rhythms during brain activation. J. Neurosci. 16, 392-417.
67. Steriade, M., Deschenes, M., Domich, L., and Mulle, C. (1985). Abolition of spindle oscillations in thalamic neurons disconnected from nucleus reticularis thalami. J. Neurophysiol. 54, 1473-1497.
68. Steriade, M., Domich, L., Oakson, G., and Deschenes, M. (1987). The deafferented reticular thalamic nucleus generates spindle rhythmicity. J. Neurophysiol. 57, 260-273.
69. Sun, Q. Q., Huguenard, J. R., and Prince, D. A. (2001). Neuropeptide Y receptors differentially modulate G- protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons. J. Physiol. (Lond.) 531, 67-79.
70. Sutton, M. A., Ito, H. T., Cressy, P., Kempf, C., Woo, J. C., and Schuman, E. M. (2006). Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell 125, 785-799.
71. Talley, E. M., Cribbs, L. L., Lee, J. H., Daud, A., Perez-Reyes, E., and Bayliss, D. A. (1999). Differential distribution of three members of a gene family encoding low voltage-activated (Ttype) calcium channels. J. Neurosci. 19, 1895-1911.
72. Turner, J. P., and Salt, T. E. (2003). Group II and III metabotropic glutamate receptors and the control of the nucleus reticularis thalami input to rat thalamocortical neurones in vitro. Neuroscience 122, 459-469.
73. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., and Javitt, D. C. (2000). Ketamine-induced defi cits in auditory and visual contextdependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57, 1139-1147.
74. Vaisanen, J., Ihalainen, J., Tanila, H., and Castren, E. (2004). Effects of NMDAreceptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia. Cell. Mol. Neurobiol. 24, 769-780.
75. Wenzel, A., Fritschy, J. M., Mohler, H., and Benke, D. (1997). NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68, 469-478.
76. White, P. F., Way, W. L., and Trevor, A. J. (1982). Ketamineits pharmacology and therapeutic uses. Anesthesiology 56, 119-136.
77. Winterer, G., and Weinberger, D. R. (2004). Genes, dopamine and cortical signalto- noise ratio in schizophrenia. Trends Neurosci. 27, 683-690.